| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Natera, Inc. | Director | Common Stock | 5,291 | $1,212,115 | $229.09 | 30 Jan 2026 | Direct |
| LEAP THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 55,000 | 31 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NTRA | Natera, Inc. | 30 Jan 2026 | 1 | $0 | 4 | Director | 03 Feb 2026, 20:35 |
| NTRA | Natera, Inc. | 31 Oct 2025 | 1 | $0 | 4 | Director | 04 Nov 2025, 21:05 |
| NTRA | Natera, Inc. | 25 Jul 2025 | 1 | $0 | 4 | Director | 29 Jul 2025, 21:05 |
| NTRA | Natera, Inc. | 27 Jun 2025 | 1 | $0 | 4 | Director | 01 Jul 2025, 21:15 |
| NTRA | Natera, Inc. | 28 Mar 2025 | 1 | $0 | 4 | Director | 01 Apr 2025, 20:47 |
| NTRA | Natera, Inc. | 06 Mar 2025 | 0 | $0 | 3 | Director | 14 Mar 2025, 17:07 |
| NTRA | Natera, Inc. | 08 Jul 2022 | 1 | $0 | 4/A | Director | 02 Sep 2022, 20:05 |
| NTRA | Natera, Inc. | 27 May 2022 | 1 | $0 | 4 | Director | 01 Jun 2022, 21:05 |
| LPTX | LEAP THERAPEUTICS, INC. | 31 Jan 2022 | 1 | $0 | 4 | Director | 02 Feb 2022, 20:47 |
| NTRA | Natera, Inc. | 17 Nov 2021 | 2 | $0 | 4 | Director | 19 Nov 2021, 17:03 |
| LPTX | LEAP THERAPEUTICS, INC. | 08 Sep 2021 | 2 | $0 | 4 | Director | 10 Sep 2021, 21:01 |
| NTRA | Natera, Inc. | 28 May 2021 | 2 | $0 | 4 | Director | 02 Jun 2021, 19:58 |